Posts

Eli Lilly Acquires Centessa Pharmaceuticals for $6.3 Billion to Enter Sleep Disorder Market

on

Korsana Biosciences Goes Public Through Reverse Merger with Cyclerion Therapeutics

on

FDA Extends Orca Bio Orca-T Review Timeline Following Manufacturing Data Submission

on

Change in Orion Group Executive Team: Berkeley Vincent Appointed EVP of Innovative Medicines as of April 8, 2026

on

INOVIO Announces Proposed Public Offering - December 2024

on

Novo Nordisk to Cut 400 Jobs at Bloomington, Indiana Facility Amid Prior Ownership Layoffs

on

Eli Lilly's Orforglipron Obesity Pill Gains FDA Approval, Challenging Novo Nordisk's Wegovy

on

No Recent NICE Cardio Approval for Wegovy

on

Dual-Action Molecule and Drug Combos Show Promise in Treating Multiple Cancers in Mice Models

on

FDA Approves Eli Lilly's Oral GLP-1 Pill Foundayo (Orforglipron) as Response to Novo Nordisk

on

Ambrosia Raises $100M Series B to Develop Next-Generation Small Molecule GLP-1s

on

Ambrosia Biosciences Raises $100M Series B for Oral GLP-1 Drug Development

on

Merck Partners with Infinimmune on $838 Million Antibody Discovery Deal

on